Daniel Edmonston, MD, MHS
Faculty Lead
Duke Nephrology Journal Club is held virtual weekly on
Thursday morning, 8:30 a.m. to 9:00 a.m. (EST).
2024 - 2025 Nephrology Journal Club
Date | Presenter | Article |
August 8, 2024 | Daniel Edmonston |
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial PMID: 38796653 |
August 15, 2024 | Rasheeda Hall |
Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD PMID: 39133046 |
August 22, 2024 | John Musgrove |
A Randomized Trial of Intravenous Amino Acids for Kidney Protection PMID: 38865168 |
August 29, 2024 | Steven Crowley |
Cytokines, C-Reactive Protein, and Risk of Incident Hypertension in the REGARDS Study PMID: 38487890 |
September 5, 2024 | Patrick Pun | Effects of a More Selective Arteriovenous Fistula Strategy on Vascular Access Outcomes PMID: 37401775 |
September 12, 2024 | Aruna Phekoo | |
September 19, 2024 | Benjamin Catanese |
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery PMID: 39212270 |
September 26, 2024 | Michael Turk | Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure: A Target Trial Emulation Study PMID: 39159459 |
October 3, 2024 | Gentzon Hall |
PIK3CA in models of proliferative glomerulonephritis and lupus
|
October 10, 2024 | John Middleton |
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial PMID: 38214599 |
October 17, 2024 | Blake Cameron | |
October 24, 2024 | No Journal Club | No Journal Club |
October 31, 2024 | Matthew Sparks |
Review of ASN Kidney Week. Immediately following, will be the second session of the Ten-Minute Tools to Interpret the Medical Literature series: "Study Design: Randomized Clinical Trials" |
November 7, 2024 | Mary Foster |
|
November 14, 2024 | Anna Strasma | |
November 21, 2024 | Micah Schub |
Racial disparities across multiple stages of the deceased organ donation process PMID: 38211654 Immediately following, will be a session of the Ten-Minute Tools to Interpret the Medical Literature series: "Interpreting Outcomes: Modeling Repeated Measures and |
November 28, 2024 | Thanksgiving Holiday - No Journal Club | No Journal Club |
December 5, 2024 | Irma Husain | Differential induction of donor-reactive Foxp3þ regulatory T cell via blockade of CD154 vs CD40 PMID: 38552961 |
December 12, 2024 | Sachin Sreenivasan | Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy PMID: 39453772 |
December 19, 2024 | Steve Smith |
Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2 Immediately following, will be a session of Ten-Minute Tools to Interpret the Medical Literature series: “Interpreting Outcomes: Understanding Confidence Intervals and |
December 26, 2024 | No Journal Club | |
January 2, 2025 | No Journal Club | |
January 9, 2025 | Arash Ataei | |
January 16, 2025 | Matt Ellis | |
January 23, 2025 | Jasmin Tharakan | |
January 30, 2025 | Anna Williams | |
February 6, 2025 | Micah Ludwig | |
February 13, 2025 | Shweta Punj | |
February 20, 2025 | Kirsten Martin | |
February 27, 2025 | Michael Berkoben | |
March 6, 2025 | Alessandra Tomasi | |
March 13, 2025 | Timothy Hopper | |
March 20, 2025 | Jenny Varner | |
March 27, 2025 | Anika Lucas | |
April 3, 2025 | John Duronville | |
April 10, 2025 | No Journal Club | No Journal Club |
April 17, 2025 | Tomokazu Souma | |
April 24, 2025 | Matthew Sinclair | |
May 1, 2025 | Opeyemi Olabisi | |
May 8, 2025 | Rasha Raslan | |
May 15, 2025 | Palavi Vaidya | |
May 22, 2025 | Rebecca Frazier | |
May 29, 2025 | Robert Spurney | |
June 5, 2025 | Aarushi Varshney | |
June 12, 2025 | Susan Murray | |
June 19, 2025 | Juneteenth Holiday - No Journal Club | No Journal Club |
June 26, 2025 | Eugene C. Kovalik | |
July 3, 2025 | No Journal Club | No Journal Club |
Past Journal Clubs and Articles
Date | Speaker | Articles |
---|---|---|
7/15/21
|
Strasma |
Gaudry et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021 Apr 3;397(10281):1293-1300. |
7/22/21 |
Husain |
No article available |
7/29/21
|
Pun Souma |
Keiichi Sumida et al. Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis. JASN April 2021, 32 (4) 950-959 Rudman-Melnick et al. Single-Cell Profiling of AKI in a Murine Model Reveals Novel Transcriptional Signatures, Profibrotic Phenotype, and Epithelial-to-Stromal Crosstalk. JASN December 2020, 31 (12) 2793-2814 |
8/12/21 |
Cameron |
Chertow et al. Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD. N Engl J Med. 2021 Apr 29;384(17):1589-1600. |
8/19/21 |
Savedchuk |
The Overview of Tolvaptan Trials for ADPKD. |
8/26/21 |
Grand |
Ogata et al. Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial. JAMA. 2021 May 18;325(19):1946-1954. |
9/2/21 |
Pun |
Research in Progress |
9/9/21 |
Murray Foster |
Pyfrom et al. The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients. Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2024624118. |
9/16/21 |
Roberts |
Anker et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021 Aug 27. Online ahead of print. Packer et al. Empagliflozin and Major Renal Outcomes in Heart Failure. N Engl J Med. 2021 Aug 27. Online ahead of print. |
9/23/21 |
Geherty
Sanoff |
Pitt et al. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med. 2021 Aug 28. Online ahead of print. Reese et al. Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and |
9/30/21 |
Smith Sparks |
Cooper et al. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis. Watanabe et al. Renin Cell Baroreceptor, a Nuclear Mechanotransducer Central for Homeostasis. Circ Res. 2021 Jul 9;129(2):262-276. |
10/14/21 |
Cameron |
Liu et al. Accounting for Age in the Definition of Chronic Kidney Disease. JAMA Intern Med. 2021 Oct 1;181(10):1359-1366. |
10/21/21 |
Kovalik |
Sun et al. Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes. Clin J Am Soc Nephrol. 2021 Aug;16(8):1201-1209. |
11/4/21 |
Berkoben |
Sterns et al. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986 Jun 12;314(24):1535-42. |
11/11/21 |
Yang |
Research in Progress |
11/18/21 |
Kourany
Jones |
Agarwal et al. Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease. N Engl J Med. 2021 Nov 5. Zampieri et al. Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA. 2021;326(9):818–829. |
12/2/21 |
Middleton
Lehrich |
Heerspink et al. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function. Kidney Int. 2021 Sep 22;S0085-2538(21)00865-6. Sibbel et al. Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 Vaccines in Patients on Hemodialysis. J Am Soc Nephrol. 2021 Nov 17;ASN.2021060778. |
12/9/21 |
R. Hall |
Kimura et al. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD. Clin J Am Soc Nephrol. 2021 Nov 15;CJN.03940321. |
12/16/21 |
Diamantidis
Crowley |
Killian et al. Evaluation of Community-Level Vulnerability and Racial Disparities Thomas et al. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced |
12/30/21 |
CANCELLED |
|
1/6/22 | CANCELLED | |
1/13/22 |
Nystrom Katz-Greenberg |
Watts AJB, et al. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2022 Jan;33(1):238-252. PMID: 34732507. Asrani et al. Mission accomplished? Early data from the simultaneous liver-kidney transplantation allocation policy. Am J Transplant. 2021 Nov;21(11):3513-3515. |
1/20/22 |
Opeyemi Olabisi |
Research in Progress |
1/27/22 |
Smith
|
Wang et al. Accuracy of Ultrasound Jugular Venous Pressure Height in Predicting Central Venous Congestion. Ann Intern Med. 2021 Dec 28. Online ahead of print. |
2/3/22 |
Duronville Onukwuli |
Singh et al. Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. N Engl J Med 2021; 385:2325-2335 Gerstein et al. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. N Engl J Med 2021; 385:896-907. |
2/10/22 |
Ashley-Koch |
Research in Progress |
2/17/22 |
Robbins Middleton |
Fernández-Juárez G, et al STARMEN Investigators. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. Kidney Int. 2021 Apr;99(4):986-998. PMID: 33166580. Johansen KL, et al. Catheter-Associated Bloodstream Infections among Patients on Hemodialysis: Progress before and during the COVID-19 Pandemic. Clin J Am Soc Nephrol. 2022 Feb 2:CJN.11360821. doi: 10.2215/CJN.11360821. Epub ahead of print. PMID: 35110377. |
2/24/22 |
Ellis Schub |
Ibrahim H et al. Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors. JASN. 2021 Nov; 32(11) 2933-2947. Paige M. et al. First clinical-grade porcine kidney xenotransplant using a human decedent model. American Journal of Transplantation. 2022 Jan. Online ahead of print. PMID: 35049121. |
3/3/22 |
Wang |
MacIntyre et al. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 2022;145 (6):416–423. PMID: 35130054. |
3/10/22 |
Diamantidis |
Research in Progress |
3/17/22 |
Kourany |
Chow CK et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. Lancet. 2021 Sep 18;398(10305):1043-1052. PMID: 34469767 |
3/24/22 |
Berkoben Sanoff |
Stremke ER, Wiese GN, Moe SM, et al. Intestinal Phosphorus Absorption in Moderate CKD and Healthy Adults Determined Using a Radioisotopic Tracer. J Am Soc Nephrol 32: 2057-2069, 2021. PMID: 34244325 Budde et al. Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial. |
4/14/22 |
Butterly Edmonston |
Shaman et al. Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER. Circulation. 2022 Feb 22;145(8):575-585. PMID: 34903039 Massy et al. Association of Serum Phosphate with Efficacy of Statin |
4/21/22 |
Kovalik Sinclair |
Kramers et al. Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial. Clin J Am Soc Nephrol. 2022 Apr;17(4):507-517. Fried et al. High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database. Nephrol Dial Transplant. 2022 Apr 7 |
4/28/22 |
Spurney |
Research in Progress |
5/5/22 |
Katz-Greenberg Musgrove |
Wayda et al. Optimal patient selection for simultaneous heart-kidney Provenzano et al. Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial. J Am Soc Nephrol. 2022 Apr 19 |
5/12/22 |
Ortiz |
Arnaud et al. Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms. J Am Soc Nephrol. 2022 Jun;33(6):1154-1171. |
5/19/22 |
Crowley |
Research In Progress |
5/26/22 |
Foster |
Research in Progress |
6/2/22 |
Lucas |
Tita et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. |
6/9/22 |
Souma |
Research in Progress |
6/16/22 |
Edmonston |
Research in Progress |
6/23/22 | Sinclair |
Research in Progress |
6/30/22 | G. Hall |
Research in Progress |